Kevin Kalinsky, MD, MS Winship Cancer Institute Associate Professor of Hematology and Medical Oncology, Emory University School of Medicine, Chair of the Louisa and Lund Gren...
“Convincing” data support the use of trastuzumab deluxtecan in patients with HER2-low metastatic breast cancer and sacituzumab gobitecan in patients with triple-negative breast cancer or hormone...
Recent Comments